Business
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
Dr. Dennis K. McBride, PhD (CAPT, Medical Service Corps, US Navy, Ret., Distinguished Research Fellow, National Defense University, and former senior
About this update from Nrx Pharmaceuticals, Inc.
[{"type":"text","content":"Dr. Dennis K. McBride, PhD (CAPT, Medical Service Corps, US Navy, Ret., Distinguished Research Fellow, National Defense University, and former senior executive, Office Secretary of Defense) to serve as first President of NRx Defense SystemsDevelopment initiative to be conducted through NRx Defense Systems, Inc., a newly incorporated R&D subsidiary, in partnership with Zeta Surgical, Inc. Initial focus will be the development of Combined Neuroplastic Therapy including D-Cycloserine (NRX-101) and Robotic-enabled Transcranial Magnetic Stimulation in the military and first-responder setting MIAMI, April 15, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the incorporation of NRx Defense Systems, Inc., a Florida-based Research and Development subsidiary. The subsidiary is charged with development of neuroplastic treatments that combine D-cycloserine with Transcranial Magnetic Stimulation (TMS) under robotic-enabled neuro-navigation, using already developed technology. The Company anticipates participating in future government and non-governmental research and development on a basis that is non-dilutive to current shareholders. NRx Defense Systems will be led by Dr. Dennis McBride, whose career spans the intersection of CNS disorders, neuroplastic therapy, and robotics. Dr. McBride began his career in Naval Aviation as a graduate of Navy Flight Surgeon School and went on to serve as a Naval Aerospace Experimental (Engineering) Psychologist across six high-technology laboratories. He later served as Program Manager at the Defense Advanced Research Projects Agency (DARPA) and as tri-Service Program Manager at the Naval Medical Research and Development Command. Following his retirement at the grade of Captain (O-6), Dr. McBride served as President of the Potomac Institute for Policy Studies before being appointed via Intergovernmental Personnel Act (IPA) as Distinguished Research Fellow and Director of the Center for Technology and National Security Policy at the National Defense University, appointed at the SES-4 level (flag officer equivalent). Dr. McBride subsequently held leadership roles in the Office of the Secretary of Defense, including as Director of the SECDEF Acquisition Innovation...